Annual FCF
-$61.42 M
-$28.73 M-87.89%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual free cash flow is -$61.42 million, with the most recent change of -$28.73 million (-87.89%) on December 31, 2023.
- During the last 3 years, ELVN annual FCF has fallen by -$52.43 million (-583.18%).
- ELVN annual FCF is now -583.18% below its all-time high of -$8.99 million, reached on December 1, 2020.
Performance
ELVN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$12.21 M
+$8.22 M+40.23%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly free cash flow is -$12.21 million, with the most recent change of +$8.22 million (+40.23%) on September 30, 2024.
- Over the past year, ELVN quarterly FCF has increased by +$11.17 million (+47.76%).
- ELVN quarterly FCF is now -89.06% below its all-time high of -$6.46 million, reached on September 30, 2022.
Performance
ELVN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$68.53 M
+$3.69 M+5.12%
September 30, 2024
Summary
- As of February 7, 2025, ELVN TTM free cash flow is -$68.53 million, with the most recent change of +$3.69 million (+5.12%) on September 30, 2024.
- Over the past year, ELVN TTM FCF has dropped by -$4.61 million (-7.20%).
- ELVN TTM FCF is now -549.26% below its all-time high of -$10.55 million, reached on March 1, 2022.
Performance
ELVN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ELVN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.9% | +47.8% | -7.2% |
| 3 y3 years | -583.2% | +41.5% | -59.3% |
| 5 y5 years | -583.2% | +41.5% | -59.3% |
ELVN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -217.8% | at low | -89.1% | +47.8% | -549.3% | +5.1% |
| 5 y | 5-year | -583.2% | at low | -89.1% | +47.8% | -549.3% | +5.1% |
| alltime | all time | -583.2% | at low | -89.1% | +47.8% | -549.3% | +5.1% |
Enliven Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.21 M(-40.2%) | -$68.53 M(-5.1%) |
| Jun 2024 | - | -$20.44 M(-12.6%) | -$72.22 M(+13.0%) |
| Mar 2024 | - | -$23.38 M(+87.1%) | -$63.92 M(+4.1%) |
| Dec 2023 | -$61.42 M | -$12.50 M(-21.5%) | -$61.42 M(+7.4%) |
| Sep 2023 | - | -$15.91 M(+31.1%) | -$57.17 M(+19.8%) |
| Jun 2023 | - | -$12.14 M(-41.9%) | -$47.72 M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$20.88 M(+153.2%) | -$43.01 M(+31.6%) |
| Dec 2022 | -$32.69 M(+69.2%) | -$8.25 M(+27.6%) | -$32.69 M(+33.7%) |
| Sep 2022 | - | -$6.46 M(-13.0%) | -$24.44 M(+35.9%) |
| Jun 2022 | - | -$7.43 M(-29.6%) | -$17.98 M(+70.4%) |
| Mar 2022 | - | -$10.55 M | -$10.55 M |
| Dec 2021 | -$19.32 M(+115.0%) | - | - |
| Dec 2020 | -$8.99 M | - | - |
FAQ
- What is Enliven Therapeutics annual free cash flow?
- What is the all time high annual FCF for Enliven Therapeutics?
- What is Enliven Therapeutics annual FCF year-on-year change?
- What is Enliven Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly FCF year-on-year change?
- What is Enliven Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Enliven Therapeutics?
- What is Enliven Therapeutics TTM FCF year-on-year change?
What is Enliven Therapeutics annual free cash flow?
The current annual FCF of ELVN is -$61.42 M
What is the all time high annual FCF for Enliven Therapeutics?
Enliven Therapeutics all-time high annual free cash flow is -$8.99 M
What is Enliven Therapeutics annual FCF year-on-year change?
Over the past year, ELVN annual free cash flow has changed by -$28.73 M (-87.89%)
What is Enliven Therapeutics quarterly free cash flow?
The current quarterly FCF of ELVN is -$12.21 M
What is the all time high quarterly FCF for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly free cash flow is -$6.46 M
What is Enliven Therapeutics quarterly FCF year-on-year change?
Over the past year, ELVN quarterly free cash flow has changed by +$11.17 M (+47.76%)
What is Enliven Therapeutics TTM free cash flow?
The current TTM FCF of ELVN is -$68.53 M
What is the all time high TTM FCF for Enliven Therapeutics?
Enliven Therapeutics all-time high TTM free cash flow is -$10.55 M
What is Enliven Therapeutics TTM FCF year-on-year change?
Over the past year, ELVN TTM free cash flow has changed by -$4.61 M (-7.20%)